Supreme Court asks 19 States and UTs to consider declaring cancer a notifiable disease

The Supreme Court's recent directive to 19 States and Union Territories to consider declaring cancer a notifiable disease marks a watershed moment in India's public health governance. To understand the magnitude of this development, we must first appreciate the historical context. India's cancer burden has been escalating alarmingly — according to the Indian Council of Medical Research (ICMR), the country recorded over 14.6 lakh new cancer cases in 2022, with projections indicating a 12.8% increase by 2025. Yet, until recently, cancer reporting remained fragmented, voluntary, and inconsistent across states. The concept of 'notifiable diseases' originates from the Epidemic Diseases Act, 1897, a colonial-era legislation that empowers state governments to mandate reporting of specified infectious diseases to health authorities. Traditionally applied to communicable diseases like cholera, plague, and more recently COVID-19, extending this framework to a non-communicable disease (NCD) like cancer represents a paradigm shift in public health thinking. The judicial intervention came through a Public Interest Litigation (PIL) highlighting the absence of a centralized cancer registry and the consequent policy blind spots. The bench headed by Chief Justice of India Surya Kant recognized that without mandatory reporting, the government cannot accurately map cancer incidence, allocate resources, plan tertiary care centers, or monitor treatment outcomes. Currently, only 17 States/UTs — including Karnataka, Gujarat, Maharashtra, and Delhi — have notified cancer under their respective Public Health Acts or state-specific regulations. The remaining 19, predominantly in the Northeast, central India, and some larger states like Uttar Pradesh and Bihar, have been slow to act, often citing administrative capacity constraints. Constitutionally, this directive engages multiple provisions. Article 21 (Right to Life) has been expansively interpreted by the Supreme Court in cases like Paschim Banga Khet Mazdoor Samity (1996) and State of Punjab v. Mohinder Singh Chawla (1997) to include the right to health and emergency medical care. Article 47 (Directive Principle) enjoins the State to raise nutrition levels and improve public health. The 73rd and 74th Constitutional Amendments devolve health responsibilities to Panchayats and Municipalities, making local-level cancer surveillance feasible. Moreover, the Clinical Establishments (Registration and Regulation) Act, 2010, and the National Health Mission framework provide statutory backing for standardized reporting. The significance for India is profound. Economically, cancer imposes a catastrophic financial burden — the World Bank estimates NCDs cost India 4-10% of GDP annually. Early detection through systematic reporting can shift diagnosis from Stage III/IV to Stage I/II, reducing treatment costs by 40-60% and improving five-year survival rates from 30% to over 80% for common cancers like breast and cervical. Socially, a national cancer registry will expose regional disparities — for instance, the high incidence of gallbladder cancer in the Gangetic belt or esophageal cancer in the Northeast — enabling targeted interventions. Politically, it strengthens cooperative federalism by nudging laggard states through judicial moral authority rather than coercion. Globally, India aligns with WHO's Global Initiative for Cancer Registry Development (GICR) and the UN Sustainable Development Goal 3.4 (reduce NCD mortality by one-third by 2030). The National Cancer Registry Programme (NCRP) under ICMR currently covers only 10% of the population; universal notification could expand this to 100%. Future implications are transformative. We may see a Central legislation amending the Epidemic Diseases Act or a new Public Health Act to include NCDs. The National Digital Health Mission (Ayushman Bharat Digital Mission) can integrate cancer data with ABHA IDs for real-time surveillance. Insurance schemes like Ayushman Bharat PM-JAY can use registry data for fraud detection and package pricing. Most critically, this moves India from reactive curative care to proactive preventive oncology — a shift long overdue for a nation where cancer is now the second leading cause of death after cardiovascular diseases.